Titan Pharmaceuticals Inc (TTNP)
7.10
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
7.01
-0.09
(-1.27%)
After-Hours: 20:00
Titan Pharmaceuticals Cash from Operations (TTM): -7.092M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -7.092M |
September 30, 2023 | -6.425M |
June 30, 2023 | -6.463M |
March 31, 2023 | -7.118M |
December 31, 2022 | -8.183M |
September 30, 2022 | -7.685M |
June 30, 2022 | -8.074M |
March 31, 2022 | -8.238M |
December 31, 2021 | -7.899M |
September 30, 2021 | -11.38M |
June 30, 2021 | -12.56M |
March 31, 2021 | -14.62M |
December 31, 2020 | -17.20M |
September 30, 2020 | -16.30M |
June 30, 2020 | -16.18M |
March 31, 2020 | -16.35M |
December 31, 2019 | -15.44M |
September 30, 2019 | -15.09M |
June 30, 2019 | -14.03M |
March 31, 2019 | -11.74M |
December 31, 2018 | -8.431M |
September 30, 2018 | -8.625M |
June 30, 2018 | -9.902M |
March 31, 2018 | -10.57M |
December 31, 2017 | -12.68M |
Date | Value |
---|---|
September 30, 2017 | -11.58M |
June 30, 2017 | -10.81M |
March 31, 2017 | 5.221M |
December 31, 2016 | 6.293M |
September 30, 2016 | 6.945M |
June 30, 2016 | 7.951M |
March 31, 2016 | -7.478M |
December 31, 2015 | -7.466M |
September 30, 2015 | -7.282M |
June 30, 2015 | -6.915M |
March 31, 2015 | -6.334M |
December 31, 2014 | -5.865M |
September 30, 2014 | -6.397M |
June 30, 2014 | -7.181M |
March 31, 2014 | -9.652M |
December 31, 2013 | -9.799M |
September 30, 2013 | 1.701M |
June 30, 2013 | 1.503M |
March 31, 2013 | 2.658M |
December 31, 2012 | 1.83M |
September 30, 2012 | -9.754M |
June 30, 2012 | -10.70M |
March 31, 2012 | -14.90M |
December 31, 2011 | -14.48M |
September 30, 2011 | -15.24M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-17.20M
Minimum
Dec 2020
-6.425M
Maximum
Sep 2023
-11.39M
Average
-11.38M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Outset Medical Inc | -131.37M |
Allurion Technologies Inc | -63.98M |
AIM ImmunoTech Inc | -21.27M |
Protalix BioTherapeutics Inc | -1.318M |
Armata Pharmaceuticals Inc | -47.42M |